NIVF - רווח למניה בשנים עשר החודשים האחרונים NewGenIvf Corp

NewGenIvf Group Limited capitalizes on the growing demand for IVF and surrogacy in Southeast Asia. This 12-month net income per share chart illustrates the market reaction to these earnings. A steady influx of patient funds protects capital, while the integration of AI into reproductive medicine opens new horizons. The value of 10182.50 is recorded as the baseline value for this metric.

Net income per share over 12 months measures the actual return of a single security by stripping the financial result of the influence of the total number of shares issued. The implementation of digital document management and ESG standards across NewGenIvf Group (NIVF) clinics optimizes costs, directly impacting the calculation of this metric. By analyzing the current trailing 12-month EPS, an investor filters out random market fluctuations. This allows for the identification of a sustainable profit generation corridor. A stable trend confirms the fundamental strength of the business model.